We know him as the lead singer for legendary rock band Poison who captured international attention a couple of years ago with his Celebrity Apprentice win.
He’s also been the new face of the American Diabetes Association for the past few years. But now, Bret Michaels is expanding his involvement with the Juvenile Diabetes Research Foundation (JDRF).
On Saturday, Bret came to Indianapolis to rock the 15th annual Promise Gala and help bring in about…
Read more »
Brenda Novak is best known to the world as a New York Times best-selling author of historical and contemporary romance novels. But to the diabetes community, she’s famous for being the founder of Brenda Novak’s Annual Auction for the Cure of Diabetes, which has raised more than $1 million for diabetes research. It’s not just a one-shot (pardon the pun!) deal. The auction takes place over not just one evening, or even one day — but…
Read more »
By
AmyT on
March 14, 2012
{Editor’s note: This is the first of a two-part interview with ADA CEO Larry Hausner}
We grassroots patient advocates are typically pretty skeptical of the ADA: Aren’t they tied too closely to industry? Who knows what their real agenda is…? My interest was piqued when we at the ‘Mine received the organization’s statement about a new four-year strategic plan, for our year-end preview of the 2012 plans of the country’s top advocacy groups. The ADA…
Read more »
By
AmyT on
February 27, 2012
The famous and controversial diabetes cure researcher Dr. Denise Faustman has just published exciting new research results showing evidence that “insulin production may persist for decades after the onset of type 1 diabetes” and “beta cell functioning also appears to be preserved in some patients years after apparent loss of pancreatic function.” Her study results appears in the March issue of the journal Diabetes Care.
“The traditional concept is that in type 1 diabetes, the…
Read more »
The Artificial Pancreas has the potential to become a huge leap forward in diabetes care. As anxious as all of us are to push the boundaries in diabetes technology, we can’t forget the importance of clinical trials; nothing will move forward without real patients ready and willing to strap on the gear and let researchers observe them for hours on end, most of the time in a clinical setting.
That might not seem like the…
Read more »
